Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence.
Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence.
复制标题
DOI:
10.1097/qai.0b013e318285d951
复制
发表时间:
2013-05-01
期刊:
影响因子:
--
通讯作者:
Goggin K
中科院分区:
文献类型:
--
作者:
Rasu RS;Malewski DF;Banderas JW;Malomo Thomson D;Goggin K
To provide data on the actual costs associated with behavioral ART adherence interventions and electronic drug monitoring used in a clinical trial to inform their implementation in future studies and real-world practice. Direct and time costs were calculated from a multi-site three-arm randomized controlled ART adherence trial. HIV positive participants (n = 204) were randomized to standard care (SC), enhanced counseling (EC), or EC and modified directly observed therapy (mDOT) interventions. Electronic drug monitoring (EDM) was used. Costs were calculated for various components of the 24-week adherence intervention. This economic evaluation was conducted from the perspective of an agency that may wish to implement these strategies. Sensitivity analyses were conducted to examine costs and savings associated with different scenarios. Total direct costs were $126,068 ($618/patient). Initial time costs were $53,590 ($262/patient). Base cost of labor was $0.36/minute. EC costs for 134 patients were $18,427 ($137/patient) and mDOT for 64 patients cost $18,638 ($291/patient). Total per patient costs were: SC=$880, EC=$1,018, EC/mDOT=$1,309. Removing driving costs evidenced the most variable impact on savings between the three study arms. The tornado diagram (sensitivity analysis) showed a graphical representation of how each sensitivity assumption reduced costs compared to each other and the resulting comparative costs for each group. This novel economic analysis provides valuable cost information to guide treatment implementation and research design decisions.